Radner Helga
Department of Internal Medicine III, Division of Rheumatology, Medical University Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria.
Wien Klin Wochenschr. 2016 Nov;128(21-22):786-790. doi: 10.1007/s00508-016-1090-x. Epub 2016 Oct 13.
In recent years, multimorbidity in rheumatic conditions has gained increasing attention. Rheumatologist care for an aging patient population with multiple diseases, therefore multimorbidity is the rule, not the exception. Owing to the high prevalence and the potential interaction of coexisting diseases, multimorbidity needs to be taken into account when treating patients with chronic inflammatory conditions. In this review we address the most prevalent comorbidities in patients with rheumatic conditions and their impact on important outcomes, such as physical function, quality of life, and mortality.
近年来,风湿性疾病中的共病现象日益受到关注。风湿病学家诊治的是患有多种疾病的老年患者群体,因此共病是常态,而非例外。由于共存疾病的高患病率以及潜在的相互作用,在治疗慢性炎症性疾病患者时需要考虑共病情况。在本综述中,我们探讨了风湿性疾病患者中最常见的共病及其对重要结局的影响,如身体功能、生活质量和死亡率。